Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.24.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue, net $ 40,214 $ 31,838
Cost of revenue 16,310 13,607
Gross profit 23,904 18,231
Operating expenses:    
Sales and marketing 10,233 9,125
Research and development 636 703
General and administrative 9,363 10,973
Acquisition related amortization expense 861 1,270
Change in fair value of contingent consideration 7 (223)
Total operating expenses 21,100 21,848
Operating income (loss) from continuing operations 2,804 (3,617)
Interest accretion expense (112) (158)
Note payable interest expense (896) (850)
Other expense, net (667) (1,211)
Income (loss) from continuing operations before tax 1,129 (5,836)
Provision for income taxes 17 29
Income (loss) from continuing operations 1,112 (5,865)
Loss from discontinued operations, net of tax (310) (16,093)
Net income (loss) $ 802 $ (21,958)
Basic net income (loss) per share of common stock:    
From continuing operations $ 0.26 $ (1.38)
From discontinued operations (0.07) (3.80)
Net income (loss) per basic share of common stock 0.19 (5.18)
Diluted net income (loss) per share of common stock:    
From continuing operations 0.25 (1.38)
From discontinued operations (0.07) (3.80)
Net income (loss) per diluted share of common stock $ 0.18 $ (5.18)
Weighted average number of common shares and common share equivalents outstanding:    
Basic 4,317 4,238
Diluted 4,364 4,238